# Study of Motilitone to Treat Functional Dyspepsia

> **NCT02365701** · PHASE2 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 45 (actual)

## Conditions studied

- Dyspepsia

## Interventions

- **DRUG:** Motilitone 30mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02365701
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02365701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02365701, "Study of Motilitone to Treat Functional Dyspepsia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02365701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*